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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A163CS 200 mg/mL at 24 hours signiﬁcantly increased ATP production com-
pared to basal condition (0,55 mM vs 0,65 mM). After TNFa stimulation,
ATP production fell to 0,40 mM; but also in this case, CSwas able to inhibit
TNFa effect increasing the ATP synthesis up to 0,62 mM. Furthermore, we
have evaluated the effect ofCS on NO and ROS production. CS was able to
reduce NO synthesis induced by IL1b, TNFa or LPS. The NO levels were
reduced after cytokine stimulation up to 21%, 32% and 31% respectively.
On the other hand, in presence of IL1b, ROS production and SOD2 activity
were increased. In this case, intracellular ROS production as well as SOD
activity decreased in CS treated chondrocytes at an average of 80%. The
decreasewasmoremarked (up to 62%)whenwe speciﬁcally analysed the
mitochondrial isoform of this important antioxidant enzyme (SOD2).
Conclusions: In summary, CS improves mitochondrial activity in
human OA chondrocytes by affecting several mitochondrial processes.
The mitochondrial membrane hyperpolarization and the increased ATP
production could correlate with a greater resistance of CS treated
chondrocytes to apoptosis.Moreover, the reduction of NO and ROS
levels, as well as the reduction in SOD2 activity, provide evidence of the
effect of CS on oxidative stress regulation.
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EFFECT ON THE CHONDROCYTE PHENOTYPE BY SPECIFICALLY
INHIBITING THE b-CATENIN DEPENDENT WNT SIGNALING USING
SMALL PEPTIDES
A. Held y, A. Glas z, T. Grossmann z, T. Pap y, J. Bertrand y. y Inst. of
Experimental Musculoskeletal Med., Munster, Germany; zChemical
Genomics Ctr. (CGC) of the Max Planck Society, Dortmund, Germany
Purpose: In osteoarthritis (OA), chondrocytes undergo hypertrophic
differentiation. In course of phenotypic change of chondrocytes, the
matrix is remodeled, including down-regulation of genes such as ACAN,
COL2A1 and MMP13. One of the signaling pathways involved in this
chondrocyte differentiation is the canonical b-catenin dependent WNT
signaling pathway. SAH-BCL9 (stabilized alpha-helix of Bcl9) and StAx-
35R (stapled axin b-catenin binding domains), two small peptides have
been developed to inhibit the oncogenic canonical- WNT signaling by
directly targeting b-catenin. We hypothesized that SAH-BCL9 and StAx-
35R may inhibit the dedifferentiation of chondrocytes towards hyper-
trophy and may reduce OA-like changes in the cartilage.
Methods: In vitro analyses were performed using primary chondrocytes
isolated from neonatal mice. The peptides SAH-BCL9 and StAx-35R were
synthesized and provided by the Grossmann Lab at the Chemical
Genomics Centre (CGC) of theMax Planck Society in Dortmund, Germany.
Micromass cultures were stained with alcian blue to examine the pro-
teoglycanproduction. Expressionofmarkergenes (ACAN,COL2A1,MMP13
and AXIN2)wasmeasured by quantitative RT-PCR. Effects of the inhibitors
on the phosphorylation of LRP6 and on total b-catenin were analyzed
using Western Blot. With dual luciferase assays the efﬁcacy of the inhib-
itors on the TCF/LEF blockade was tested. Intracellular localization of the
inhibitors was investigated by using confocal laser microscopy.
Results: Based on ﬁrst results, confocal laser microscopy demonstrated
intracellular but not intranuclear localization of FITC-labeled SAH-BCL9
and StAx-35R peptides in primary chondrocytes and C28 cells, chon-
drocyte-like immortalized cells. Treatment of hip caps with inhibitors
showed better penetration into cartilage for SAH-BCL9, but not for StAx-
35R, independent of previous IL-1 treatment. TCF/LEF promotor activity
was reduced by application of increasing concentrations of SAH-BCL9,
but not with StAx-35R, upon simultaneous induction of the canonical
WNT signaling with WNT3A. Western blot analysis revealed that StAx-
35R did not affect pLRP6 and b-catenin. However ﬁrst results indicated
less phosphorylation of LRP6 and less stabilization of b-catenin when
cells were treated with SAH-BCL9 and WNT3A compared to cells which
were only treated with WNT3A alone. Quantitative RT-PCR showed
decreased expression of aggrecan, collagen type II and MMP13 upon
stimulation with WNT3A, which was not rescued to baseline by treat-
ment withWNT3A and either one of the inhibitors. Expression of Axin2,
a target gene of the canonical WNT signaling pathway, was increased by
WNT3A and still enhanced when cells were treated simultaneously
withWNT3A and SAH-BCL9 or StAx-35R.With regard to the phenotypic
stability of chondrocytes, alcian blue staining of micromass cultures
showed that WNT3A treatment led to proteoglycan loss, which could
not be reduced by using the small peptides.
Conclusions: Our data indicate that SAH-BCL9 inhibits the b-catenin
dependent WNT signaling pathway on protein level and functionally
with regard to the TCF/LEF reporter activity at high concentrations.Despite both - SAH-BCL9 and StAx-35R - appear to be not able to reverse
WNT3A induced changes on the chondrocyte phenotype.
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EFFECT OF GROWTH HORMONE AND HYALURONAN AMIDE
DERIVATIVE ON HUMAN OSTEOARTHRITIC CHONDROCYTES
F. Paolella y, E. Gabusi y, C. Manferdini y, L. Gambari y, A. Schiavinato z,
B. Grigolo y, G. Lisignoli y. y Istituto Ortopedico Rizzoli, Bologna, Italy;
z Fidia Farmaceutici s.p.a., Abano Terme, Padova, Italy
Purpose: Knee osteoarthritis (OA) is one of the main causes of pain and
disability and signiﬁcantly affects the patients’ quality of life. The
homeostasis of articular cartilage is mediated by a complex network of
interactions mainly due to locally produced growth factors, ECM com-
ponents and circulating hormones. The development of pharmaco-
logical treatments with the potential for structure-modifying activity in
OA joint treatment has become a major focus in the ﬁeld of OA research.
Aim of this study was to evaluate the effects of hyaluronan amide
derivative (HYADD®4-G, HAD) alone or in combination with human
growth hormone (hGH) on OA chondrocytes.
Methods: Chondrocytes were isolated from cartilage of OA patients
undergoing knee arthroplasty. Chondrocytes were treated with differ-
ent concentrations of hGH (from 0.01mg/ml to10mg/ml) with or without
HAD (1mg/ml) and analyzed at different time points (24, 48, 72 hours
and after 7 days). They were analyzed for: 1.the presence of GHR and
CD44 by immunocytochemistry, 2. cell viability by vital dye, 3. meta-
bolic activity by alamar blue assay, 4. the release of IGF-1, FGF2 and IL6
by immunoassay tests, 5. gene expression of collagen type 1, collagen
type 2, collagen type 10 and SOCS2 by qRT-PCR.
Results: OA chondrocytes express GH receptor and all doses of hGH
tested not affected cell viability and metabolic activity, as well as, the
expression of collagen type 2, 1, or 10 and the release of insulin like
growth factor-1 (IGF-1) or ﬁbroblast growth factor-2 (FGF-2) or IL6. hGH
treatment increased the expression of hyaluronan receptor CD44. HAD
alone or combined with hGH reduced metabolic activity, the release of
IL6 and the gene expression of collagen type 1, 2 and 10 , except SOCS2,
that was increased. Interestingly, all the parameters analyzed propor-
tionally decreased with increasing age of the patients.
Conclusions: hGH did not induce human chondrocyte metabolic
activity and did not affect typical chondrocytic (collagen type 2) or
ﬁbrotic or hypertrophic (collagen type 1 and 10) marker expression or
IGF1 or FGF2 or IL6 release but induced CD44 receptor. HAD reduced all
the effects induced by hGH on human OA chondrocytes partially
through a signiﬁcant induction of SOCS2 expression. It has been dem-
onstrated that SOCS2 is signiﬁcantly reduced in OA chondrocytes and
our preliminary results demonstrate an unknown interplays between
hGH and hyaluronic acid probably due to SOCS2.
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SANGUIS DRACONIS RESIN STIMULATES THE OSTEOGENESIS IN
OSTEOBLASTIC MC3T3-E1 CELLS IN VITRO
W. Wang y, P. Yuan z, X. Guo x. y The Second Afﬁliated Hosp., Xian Jiaotong
Uinversity, Xian, China; z Shaanxi Traditional Chinese Med. Coll., Xianyang,
China; xDept. of Publ. Hlth., Med. Coll., Key Lab. of Environment and Genes
Related to Diseases, Xian Jiaotong Uinversity, Xian, China
Purpose: Sanguis Draconis (SD)is a resin that is obtained from Dae-
monorops draco (Palmae). Used in traditional medicine, it has shown
activity in the prevention of osteoporosis as well as promoting the
healing of bone fractures.The purpose of this study was to investigate
the effect of SD on the MC3T3-E1 cells in vitro.
Methods: In this study, the effects of Sanguis Dranonis ethanol extract
on b-glycerolphosphate and ascorbic acid induced differentiation using
mouse calvaria origin MC3T3-E1 osteoblastic cells was examined. We
looked at osteoblast differentiation, proliferation, andmineralization by
measuring alkaline phosphatase (ALP) and speciﬁc bone marker activ-
ities. Osteoblast-like MC3T3-E1 cells were cultured in various concen-
trations of SD ethanol extract (0.005-1 mg/mL) during the osteoblast
differentiation period (1, 5, 15, and 25 days).
Results: As measured by 3-[4,5-dimethylthiazol-2-y]-2,5-diphenylte-
trazolium bromide assay, SD extracts increased cell proliferation as
compared to control. The most pronounced effect was observed at the
concentration range between 0.01 and 0.1 mg/mL (P<0.01). This SD
stimulatory effect for cell proliferation was observed during the whole
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A164osteogenic period. Cellular (synthesized) ALP activity was increased
during 15 days of culture, and was conﬁrmed by the staining of ALP
activity on cell matrix layers formatrix calciﬁcation. SD stimulatory effect
for cell mineralization we observed in 14 and 21 days. Elevated mRNA or
protein levels of bone morphogenetic protein-2(BMP 2), the differ-
entiation marker osteocalcin, osteopontin, collgen I, and a master
osteogenic transcription factor, Runx2, were observed in SD-treated cells.
Conclusions: These results suggest that SD may increase osteogenic
effect by stimulating cell ALP activity and affect the BMP signaling
pathway cascades in osteoblastic cells, then promotes osteoblast dif-
ferentiation, mineralization, and bone formation.
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THE EFFECT OF PALMITATE ON HUMAN ARTICULAR CHONDROCYTES
IS PARTIALLY REVERSED BY OLEIC ACID
M. Vazquez Mosquera, A. Soto Hermida, M. Fernandez Moreno,
E. Cortes Pereira, S. Rela~no Fernandez, J. Fernandez Tajes,
N. Oreiro Villar, C. Fernandez Lopez, I. Rego Perez, F. Blanco García. Inst.
de Investigacion Biomedica de A Coru~na (INIBIC), CHUAC.UDC, A Coru~na,
Spain
Purpose: Osteoarthritis is a heterogeneous disease and metabolic fac-
tors contribute substantially to its pathogenesis. Conditions such as
obesity and metabolic syndrome have been directly related to osteo-
arthritis regardless of the mechanical damage. In this regard, saturated
fatty acids such as palmitate are particularly interesting, since their
circulating levels are elevated in these conditions. Palmitate causes
apoptosis, inﬂammation and mitochondrial damage in peripheral tis-
sues. Thus, the aim of this work is to analyze the effects of palmitate and
oleate (monoinsaturated fatty acid) on human chondrocytes
Methods: The TC28a2 chondrocyte cell linewas used to analyze the effect
of 0.4mM and 0.7mM palmitate (PA) and palmitate/oleate (PA/O) 1:2 for
12 hours. Isolated RNAwas retrotranscribed to cDNA to analyze the gene
expression of metalloproteinases (MMP-1, MMP-3, MMP-13), Interleukin
6 (IL6) and Cyclooxygenase 2 (COX2). We also analyzed reactive oxygen
species (ROS) production by ﬂow cytometry using MitosoxTM. Total and
mitochondrial ATP were measured using ATP Bioluminescence Assay Kit
CLS II. Apoptosis was analyzed using the Annexin V FITC/IP Apoptosis
detection kit and Caspase 3,7 and 9 activity by means of a luminescense
assay (Promega). Data analysis was performed with SPSS software(v19)
andqBase plus (Biogazelle). Statistical signiﬁcancewasdeclaredatp<0.05
Results: PA stimulation induced a signiﬁcant overexpression of MMP-3
(0.4mM/basal¼4.70±0.37; 0.7mM/basal¼5.62±1.87), MMP-13 (0.4mM/
basal¼1.2±0.13; 0.7mM/basal¼2.04±0.63), IL6 (0.4mM/
basal¼4.07±0.35; 0.7mM/basal¼2.87±0.23) and COX2(0.4mM/
basal¼1.6±0.65; 0.7mM/basal¼2.2±0.85) (p<0.05)
Mitochondrial superoxide anion was signiﬁcantly increased by 6.68-
fold (0.4mM PA) and 6.46-fold (0.7mM PA)compared tothe non-
stimulated (PA-free) cells (p<0.05). Both total and mitochondrial ATP
production were signiﬁcantly decreased in PA-stimulated cells: PA/
basal ratio 0.45 ± 0.04 (0.4mM PA) and 0.67± 0.1 (0.7mM PA)for total
ATP and 0.55±0.07 (0.4mM PA) and 0.31±0.29 (0.7mM PA)for mito-
chondrial ATP (p<0.05)
A signiﬁcant increase of apoptosis was also detected (0.4mM PA/basal
ratio¼2.32±0.04; 0.7Mm PA/basal ratio¼2.7±0.22) (p<0.05); besi-
descaspases3/7 (0.4mM PA/basal ratio¼2.37±0.19; 0.7mM PA/basal
ratio¼4.32±1.07) and caspase 9 activity (0.4mM PA/basal
ratio¼2.3±0.24; 0.7mM PA/basal ratio¼2.83±0.5) signiﬁcantly
increased after PA stimulation too (p<0.05). After pre-incubation with
5mM NAC (N-Acetylcisteine) the apoptotic effects of PA stimulation
were signiﬁcantly reversed (p<0.05)
Co-stimulation with PA/O 1:2 partially reversed the effects of PA; the
expression levels of MMP-3, MMP-13 and IL-6 as well as mitochondrial
superoxide production andcaspases 3/7 and 9 activity were sig-
niﬁcantly reduced in relation to PA-stimulated cells (p<0.05); on the
contrary, total and mitochondrial ATP showed a non-signiﬁcant
increase in relation to PA-stimulated cells
Conclusions: Palmitate overload causes an increased inﬂammatory
response and mitochondrial superoxide anion productionas well as
decreased levels of total and mitochondrial ATP. Besides, palmitate-
induced apoptosis is mediated by increased mitochondrial oxidative
stress.The effects of saturated fatty acids,related to obesity and meta-
bolic syndrome, are partially reversed by monoinsaturated fatty acids
such as Oleic acid and could help understand the metabolic phenotype
of osteoarthritis250
WATER-SOLUBLE C60-(OH)24 FULLERENE HYDROXIDE AS A
THERAPEUTIC AGENT AGAINST THE DEGENERATION OF ARTICULAR
CARTILAGE IN OSTEOARTHRITIS
N. Yui y, H. Yoshioka y, H. Fujiya y, H. Musha y, R. Karasawa z, K. Yudoh z.
yDept. of Sports Med., St. Marianna Univ. Sch. of Med., Kawasaki, Japan;
zDept. of Frontier Med., Inst. of Med. Sci., St. Marianna Univ. Sch. of
Med., Kawasaki, Japan
Purpose: During the development of osteoarthritis (OA), mechanical
stress on articular cartilage downregulates the stable cellular activities
of chondrocytes and induce the production of catabolic factors, such as
proinﬂammatory cytokines and chemokines. In addition, it is well
known that chondrocytes produce excess amounts of reactive oxygen
species (ROS; superoxide, nitric oxide, hydrogen peroxide and perox-
ynitrite) in response to mechanical stress. Recent reports have dem-
onstrated that mechanical stress to articular cartilage stimulates excess
production of ROS from chondrocytes, consequently resulting in the
depolymerization of hyaluronic acid and chondrocyte death. It has been
suggested that the generation of ROS and the depletion of cellular
antioxidants may be involved in the pathogenesis of OA.
C60 fullerene is a molecule composed completely of carbon in a unique
spherical structure that has a high reactivity with oxygen free radicals
and can potentially act as a free radical scavenger. It has been reported
that the antioxidant level of C60 is several hundred-fold higher than
that of other antioxidants. Recently, C60 fullerene has shown to inhibit
neuronal apoptosis by scavenging oxygen reactive species and protects
human skin keratinocytes from ROS-induced cell death after UV stress,
suggesting that C60 is a useful agent to protect against the oxygen free
radical-induced pathological features in a variety of diseases. Use of C60
could lead to the development of novel therapeutic strategies in the
prevention of both chondrocyte aging and cartilage degeneration.
To prevent the degeneration of articular cartilage in OA, we have newly
developed on water-soluble C60(OH)24 fullerene hydroxide, a strong
free radical scavenger, as an anti-oxidative agent. In this study, we
examined the therapeutic effects of water-soluble C60(OH)24 on
chondrocyte activity and energy metabolism, which were monitored by
the production of cartilage component (proteoglycan), matrix degrad-
ing enzyme MMP-3, and the uptake of glucose in the cells, respectively.
Methods: In thepresenceorabsence ofC60(OH)24 (1.0nM,10.0 nM,100.0
nM), humanOA chondrocyteswere incubatedwith IL-1b (1.0,10.0 ng/ml).
After the 24-hour incubationperiod, chondrocyte activities (production of
proteoglycan and MMP-3, glucose metabolism) were analyzed.
Our previous study revealed that expression of DNA repair enzyme,
apurinic/apyrimidinic endonuclease (Apex) 2, in chondrocytes was
associated with the degeneration of articular cartilages and was
induced by OA-relating catabolic factors. Thus, we also studied effects of
C60(OH)24 on the expression of Apex 2 in osteoarthritic chondrocytes.
Results: IL-1b signiﬁcantly inhibited the production of proteoglycan
and the glucose uptake in chondrocytes, and accelerated the secretion
of MMP-3 from chondrocytes. Even in the presence of IL-1b (1.0 ng/ml,
but not 10.0 ng/ml), C60(OH)24 inhibited the IL-1b-induced production
of MMP-3, the IL-1b-induced down-regulation of proteoglycan pro-
duction and glucose metabolism in OA chondrocytes. C60(OH)24 full-
erene hydroxide also reduced the OA-relating catabolic factor-induced
up-regulation of DNA repair enzyme, Apex 2, in OA chondrocytes.
Conclusions: Our data indicated that nM order of water-soluble
C60(OH)24 fullerene hydroxide may have a potential to protect against
the catabolic factor-induced down-regulation of chondrocyte activities
in OA. Our ﬁndings provide a novel pathogenic mechanism linking
oxidant-mediated degenerative process of articular cartilage in OA.
Figure 1. Effect of C60(OH)24 on MMP-3 production in chondrocytesĂ
